
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The impact of tumor stroma on drug response in breast cancer
Jürgen Dittmer, Benjamin Leyh
Seminars in Cancer Biology (2014) Vol. 31, pp. 3-15
Closed Access | Times Cited: 97
Jürgen Dittmer, Benjamin Leyh
Seminars in Cancer Biology (2014) Vol. 31, pp. 3-15
Closed Access | Times Cited: 97
Showing 1-25 of 97 citing articles:
The biology and function of fibroblasts in cancer
Raghu Kalluri
Nature reviews. Cancer (2016) Vol. 16, Iss. 9, pp. 582-598
Closed Access | Times Cited: 3434
Raghu Kalluri
Nature reviews. Cancer (2016) Vol. 16, Iss. 9, pp. 582-598
Closed Access | Times Cited: 3434
New horizons in tumor microenvironment biology: challenges and opportunities
Fei Chen, Xueqian Zhuang, Liangyu Lin, et al.
BMC Medicine (2015) Vol. 13, Iss. 1
Open Access | Times Cited: 648
Fei Chen, Xueqian Zhuang, Liangyu Lin, et al.
BMC Medicine (2015) Vol. 13, Iss. 1
Open Access | Times Cited: 648
Mechanisms of aromatase inhibitor resistance
X. Cynthia, Tomás Reinert, Izabela Chmielewska, et al.
Nature reviews. Cancer (2015) Vol. 15, Iss. 5, pp. 261-275
Closed Access | Times Cited: 362
X. Cynthia, Tomás Reinert, Izabela Chmielewska, et al.
Nature reviews. Cancer (2015) Vol. 15, Iss. 5, pp. 261-275
Closed Access | Times Cited: 362
Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins
Carrie J. Lovitt, Todd Shelper, Vicky M. Avery
BMC Cancer (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 302
Carrie J. Lovitt, Todd Shelper, Vicky M. Avery
BMC Cancer (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 302
Emerging roles of ECM remodeling processes in cancer
Vishnu Mohan, Alakesh Das, Irit Sagi
Seminars in Cancer Biology (2019) Vol. 62, pp. 192-200
Closed Access | Times Cited: 260
Vishnu Mohan, Alakesh Das, Irit Sagi
Seminars in Cancer Biology (2019) Vol. 62, pp. 192-200
Closed Access | Times Cited: 260
The role of the transcription factor Ets1 in carcinoma
Jürgen Dittmer
Seminars in Cancer Biology (2015) Vol. 35, pp. 20-38
Closed Access | Times Cited: 181
Jürgen Dittmer
Seminars in Cancer Biology (2015) Vol. 35, pp. 20-38
Closed Access | Times Cited: 181
Recent advances in understanding tumor stroma-mediated chemoresistance in breast cancer
Jana Plavá, Marina Cihova, Monika Buríková, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 149
Jana Plavá, Marina Cihova, Monika Buríková, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 149
Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment
Wen Li, Feifei Li, Xia Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 126
Wen Li, Feifei Li, Xia Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 126
The role of tumor microenvironment in drug resistance: emerging technologies to unravel breast cancer heterogeneity
Vincenzo Salemme, Giorgia Centonze, Lidia Avalle, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 42
Vincenzo Salemme, Giorgia Centonze, Lidia Avalle, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 42
Tumor-extracellular matrix interactions: Identification of tools associated with breast cancer progression
Marta Giussani, Giuseppe Merlino, Vera Cappelletti, et al.
Seminars in Cancer Biology (2015) Vol. 35, pp. 3-10
Open Access | Times Cited: 146
Marta Giussani, Giuseppe Merlino, Vera Cappelletti, et al.
Seminars in Cancer Biology (2015) Vol. 35, pp. 3-10
Open Access | Times Cited: 146
Optimal management of hormone receptor positive metastatic breast cancer in 2016
Tomás Reinert, Carlos H. Barrios
Therapeutic Advances in Medical Oncology (2015) Vol. 7, Iss. 6, pp. 304-320
Open Access | Times Cited: 127
Tomás Reinert, Carlos H. Barrios
Therapeutic Advances in Medical Oncology (2015) Vol. 7, Iss. 6, pp. 304-320
Open Access | Times Cited: 127
Co-culture of 3D tumor spheroids with fibroblasts as a model for epithelial–mesenchymal transition in vitro
Sun Ah Kim, Eun Kyung Lee, Hyo‐Jeong Kuh
Experimental Cell Research (2015) Vol. 335, Iss. 2, pp. 187-196
Closed Access | Times Cited: 106
Sun Ah Kim, Eun Kyung Lee, Hyo‐Jeong Kuh
Experimental Cell Research (2015) Vol. 335, Iss. 2, pp. 187-196
Closed Access | Times Cited: 106
The inflammatory/cancer-related IL-6/STAT3/NF-κB positive feedback loop includes AUF1 and maintains the active state of breast myofibroblasts
Siti-Fauziah Hendrayani, Bothaina Al‐Harbi, Mysoon M. Al‐Ansari, et al.
Oncotarget (2016) Vol. 7, Iss. 27, pp. 41974-41985
Open Access | Times Cited: 94
Siti-Fauziah Hendrayani, Bothaina Al‐Harbi, Mysoon M. Al‐Ansari, et al.
Oncotarget (2016) Vol. 7, Iss. 27, pp. 41974-41985
Open Access | Times Cited: 94
Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2+ Breast Cancer
Ariella B. Hanker, Mónica V. Estrada, Giampaolo Bianchini, et al.
Cancer Research (2017) Vol. 77, Iss. 12, pp. 3280-3292
Open Access | Times Cited: 91
Ariella B. Hanker, Mónica V. Estrada, Giampaolo Bianchini, et al.
Cancer Research (2017) Vol. 77, Iss. 12, pp. 3280-3292
Open Access | Times Cited: 91
Tumor-Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation
Patricia Fernández‐Nogueira, Mario Mancino, Gemma Fuster, et al.
Clinical Cancer Research (2019) Vol. 26, Iss. 6, pp. 1432-1448
Open Access | Times Cited: 82
Patricia Fernández‐Nogueira, Mario Mancino, Gemma Fuster, et al.
Clinical Cancer Research (2019) Vol. 26, Iss. 6, pp. 1432-1448
Open Access | Times Cited: 82
3D In Vitro Model for Breast Cancer Research Using Magnetic Levitation and Bioprinting Method
Fransisca Leonard, Biana Godin
Methods in molecular biology (2016), pp. 239-251
Open Access | Times Cited: 79
Fransisca Leonard, Biana Godin
Methods in molecular biology (2016), pp. 239-251
Open Access | Times Cited: 79
Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells
Svetlana Skolekova, Miroslava Matúšková, Martin Boháč, et al.
Cell Communication and Signaling (2016) Vol. 14, Iss. 1
Open Access | Times Cited: 77
Svetlana Skolekova, Miroslava Matúšková, Martin Boháč, et al.
Cell Communication and Signaling (2016) Vol. 14, Iss. 1
Open Access | Times Cited: 77
Mitochondrial markers predict recurrence, metastasis and tamoxifen-resistance in breast cancer patients: Early detection of treatment failure with companion diagnostics
Federica Sotgia, Marco Fiorillo, Michael P. Lisanti
Oncotarget (2017) Vol. 8, Iss. 40, pp. 68730-68745
Open Access | Times Cited: 76
Federica Sotgia, Marco Fiorillo, Michael P. Lisanti
Oncotarget (2017) Vol. 8, Iss. 40, pp. 68730-68745
Open Access | Times Cited: 76
Translational Horizons in the Tumor Microenvironment: Harnessing Breakthroughs and Targeting Cures
Yu Sun
Medicinal Research Reviews (2015) Vol. 35, Iss. 2
Open Access | Times Cited: 75
Yu Sun
Medicinal Research Reviews (2015) Vol. 35, Iss. 2
Open Access | Times Cited: 75
Exosomes derived from cancerous and non-cancerous cells regulate the anti-tumor response in the tumor microenvironment
Susan Bae, Jeffrey Brumbaugh, Benjamin Bonavida
Genes & Cancer (2018) Vol. 9, Iss. 3-4, pp. 87-100
Open Access | Times Cited: 71
Susan Bae, Jeffrey Brumbaugh, Benjamin Bonavida
Genes & Cancer (2018) Vol. 9, Iss. 3-4, pp. 87-100
Open Access | Times Cited: 71
Mitochondrial “power” drives tamoxifen resistance: NQO1 and GCLC are new therapeutic targets in breast cancer
Marco Fiorillo, Federica Sotgia, Diego Sisci, et al.
Oncotarget (2017) Vol. 8, Iss. 12, pp. 20309-20327
Open Access | Times Cited: 70
Marco Fiorillo, Federica Sotgia, Diego Sisci, et al.
Oncotarget (2017) Vol. 8, Iss. 12, pp. 20309-20327
Open Access | Times Cited: 70
Imaging the Tumor Microenvironment
Valerie S. LeBleu
The Cancer Journal (2015) Vol. 21, Iss. 3, pp. 174-178
Open Access | Times Cited: 69
Valerie S. LeBleu
The Cancer Journal (2015) Vol. 21, Iss. 3, pp. 174-178
Open Access | Times Cited: 69
Three-dimensional bio-printing: A new frontier in oncology research
Nitin B. Charbe, Paul A. McCarron, Murtaza M. Tambuwala
World Journal of Clinical Oncology (2017) Vol. 8, Iss. 1, pp. 21-21
Open Access | Times Cited: 64
Nitin B. Charbe, Paul A. McCarron, Murtaza M. Tambuwala
World Journal of Clinical Oncology (2017) Vol. 8, Iss. 1, pp. 21-21
Open Access | Times Cited: 64
A Role for Notch Signalling in Breast Cancer and Endocrine Resistance
Ahmet Acar, Bruno M. Simões, Robert B. Clarke, et al.
Stem Cells International (2016) Vol. 2016, Iss. 1
Open Access | Times Cited: 54
Ahmet Acar, Bruno M. Simões, Robert B. Clarke, et al.
Stem Cells International (2016) Vol. 2016, Iss. 1
Open Access | Times Cited: 54
GPER Mediates Non-Genomic Effects of Estrogen
Marco Pupo, Marcello Maggiolini, Anna Maria Musti
Methods in molecular biology (2015), pp. 471-488
Closed Access | Times Cited: 51
Marco Pupo, Marcello Maggiolini, Anna Maria Musti
Methods in molecular biology (2015), pp. 471-488
Closed Access | Times Cited: 51